Editorial: Adjuvant anthracyclines and taxanes: Quantifying the costs of therapeutic advances in breast cancer Journal Article

  

Authors:	Morris, P. G.; Bach, P. B.
Article Title:	Editorial: Adjuvant anthracyclines and taxanes: Quantifying the costs of therapeutic advances in breast cancer
Keywords:	protein expression; fluorouracil; drug efficacy; risk benefit analysis; systemic therapy; paclitaxel; cancer adjuvant therapy; comparative study; methotrexate; methodology; multiple cycle treatment; breast cancer; epidermal growth factor receptor 2; editorial; cyclophosphamide; high risk patient; docetaxel; febrile neutropenia; cost effectiveness analysis; drug cost; health care cost; hospitalization; health care system; epirubicin; cancer epidemiology; trastuzumab; granulocyte colony stimulating factor; hospitalization cost; cost benefit analysis; public health problem
Journal Title:	Onkologie
Volume:	32
Issue:	8-9
ISSN:	0378-584X
Publisher:	S. Karger AG
Date Published:	2009-09-01
Start Page:	464
End Page:	466
Language:	English
DOI:	10.1159/000227136
PROVIDER:	scopus
PUBMED:	19745589
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-70149121041&partnerID=40&md5=056fcf602891f09ba94a696b6d33608c
Notes:	--- - "Export Date: 30 November 2010" - "CODEN: ONKOD" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/1061